Literature DB >> 32057191

Comparison of the Iowa Reference Algorithm to the Heidelberg Spectralis optical coherence tomography segmentation algorithm.

Jasmine Q Sun1, Brendan McGeehan1, Kim Firn2, David Irwin3, Murray Grossman3, Gui-Shuang Ying1, Benjamin J Kim1.   

Abstract

For spectral-domain optical coherence tomography (SD-OCT) studies of neurodegeneration, it is important to understand how segmentation algorithms differ in retinal layer thickness measurements, segmentation error locations and the impact of manual correction. Using macular SD-OCT images of frontotemporal degeneration patients and controls, we compare the individual and aggregate retinal layer thickness measurements provided by two commonly used algorithms, the Iowa Reference Algorithm and Heidelberg Spectralis, with manual correction of significant segmentation errors. We demonstrate small differences of most retinal layer thickness measurements between these algorithms. Outer sectors of the Early Treatment Diabetic Retinopathy Study grid require a greater percent of eyes to be corrected than inner sectors of the retinal nerve fiber layer (RNFL). Manual corrections affect thickness measurements mildly, resulting in at most a 5% change in RNFL thickness. Our findings can inform researchers how to best use different segmentation algorithms when comparing retinal layer thicknesses.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Iowa Reference Algorithm; Spectralis; frontotemporal degeneration; optical coherence tomography; retinal layer thickness; segmentation algorithms

Mesh:

Year:  2020        PMID: 32057191     DOI: 10.1002/jbio.201960187

Source DB:  PubMed          Journal:  J Biophotonics        ISSN: 1864-063X            Impact factor:   3.207


  1 in total

1.  Retina tissue validation of optical coherence tomography determined outer nuclear layer loss in FTLD-tau.

Authors:  Benjamin J Kim; Vivian Lee; Edward B Lee; Adrienne Saludades; John Q Trojanowski; Joshua L Dunaief; Murray Grossman; David J Irwin
Journal:  Acta Neuropathol Commun       Date:  2021-11-18       Impact factor: 7.801

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.